Related Experiment Video
Updated: Nov 6, 2025

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
Published on: December 9, 2015
Estimating the state of the COVID-19 epidemic in France using a model with memory
Raphaël Forien1, Guodong Pang2, Étienne Pardoux3
1INRAE, BioSP, Centre INRAE PACA, Domaine St-Paul, 84914 Avignon Cedex FRANCE.
Abstract:
In this paper, we use a deterministic epidemic model with memory to estimate the state of the COVID-19 epidemic in France, from early March until mid-December 2020. Our model is in the SEIR class, which means that when a susceptible individual (S) becomes infected, he/she is first exposed (E), i.e. not yet contagious. Then he/she becomes infectious (I) for a certain length of time, during which he/she may infect susceptible individuals around him/her, and finally becomes removed (R), that is, either immune or dead. The specificity of our model is that it assumes a very general probability distribution for the pair of exposed and infectious periods. The law of large numbers limit of such a model is a model with memory (the future evolution of the model depends not only upon its present state, but also upon its past). We present theoretical results linking the (unobserved) parameters of the model to various quantities which are more easily measured during the early stages of an epidemic. We then apply these results to estimate the state of the COVID-19 epidemic in France, using available information on the infection fatality ratio and on the distribution of the exposed and infectious periods. Using the hospital data published daily by Santé Publique France, we gather some information on the delay between infection and hospital admission, intensive care unit (ICU) admission and hospital deaths, and on the proportion of people who have been infected up to the end of 2020.
Related Concept Videos
Steps in Outbreak Investigation
Statistical Methods for Analyzing Epidemiological Data
Causality in Epidemiology
Exponential Equations for Modeling Growth
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Principles of Disease Surveillance

